{"search_session":{},"preferences":{"l":"en","queryLanguage":"en"},"patentId":"184-158-375-761-862","frontPageModel":{"patentViewModel":{"ref":{"entityRefId":"184-158-375-761-862","entityRefType":"PATENT"},"entityMetadata":{"linkedIds":{"empty":true},"tags":[],"collections":[{"id":11663,"type":"PATENT","title":"University of Montreal - Patent Portfolio","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":2579,"tags":[],"user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"notes":[{"id":8327,"type":"COLLECTION","user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"text":"
Search Applicants and Owners separately:uni* montreal
Select more for logical variants.
Add to collection.
Select all patents in the collection and expand by simple families.
Add to collection. Total patents: 1939
Search Applicants and Owners separately:uni* montreal
Select more for logical variants.
Add to collection.
Select all patents in the collection and expand by simple families.
Add to collection. Total patents: 1939
(a) 5 to 16 amino acids long and has an amino acid sequence selected from the group consisting of: RYTPEL (SEQ ID NO:21), RYTVQLA (SEQ ID NO:15), KYTPELA (SEQ ID NO:22), RYTPDLA (SEQ ID NO:25), RYVVELA (SEQ ID NO:18), RWTPELA (SEQ ID NO:24), RYTPEL (SEQ ID NO:39), RWTPEL (SEQ ID NO:34), APRYTVALA (SEQ ID NO:7), RYTPEV (SEQ ID NO:35), and RFTPEL (SEQ ID NO:36); or\n
(b) 5 to 9 amino acids long and has an amino acid sequence selected from the group consisting of RYTVELA (SEQ ID NO:10), RYTVEL (SEQ ID NO:20), PRYTVELA (SEQ ID NO:9), YTVELA (SEQ ID NO:11), and TVELA (SEQ ID NO:12)."],"number":1,"annotation":false,"claim":true,"title":false},{"lines":["The peptide of claim 1, wherein the peptide has an amino acid sequence selected from the group consisting of: RYTPEL (SEQ ID NO:21), RYTVQLA (SEQ ID NO:15), KYTPELA (SEQ ID NO:22), and RYTPDLA (SEQ ID NO:25)."],"number":2,"annotation":false,"claim":true,"title":false},{"lines":["The peptide of claim 1, wherein the peptide consists of the amino acid sequence RYTVELA (SEQ ID NO:10)."],"number":3,"annotation":false,"claim":true,"title":false},{"lines":["A method for treating an IL-1-related disease, disorder or condition in an animal comprising: administering to said animal a therapeutically effective amount of a peptide according to claim 1, wherein the IL-1-related disease, disorder or condition is an inflammatory bowel disease, an inflammatory joint disease or psoriasis."],"number":4,"annotation":false,"claim":true,"title":false},{"lines":["A pharmaceutical composition comprising at least one peptide of claim 1 and a pharmaceutically acceptable excipient."],"number":5,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 4, wherein the IL-1-related disease, disorder or condition is an inflammatory bowel disease."],"number":6,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein said animal is a human patient."],"number":7,"annotation":false,"claim":true,"title":false},{"lines":["The peptide of claim 1, wherein the amino acid sequence contains at least one D-amino acid."],"number":8,"annotation":false,"claim":true,"title":false},{"lines":["The peptide of claim 1, wherein said peptide contains amino acids selected from the group consisting of L-amino acid, D-amino acid, and a mixture thereof."],"number":9,"annotation":false,"claim":true,"title":false},{"lines":["The peptide of claim 1, wherein the amino acid sequence comprises one or more modifications to increase protease resistance, serum stability and/or bioavailability."],"number":10,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 6, wherein the inflammatory bowel disease is Crohn's disease."],"number":11,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 6, wherein the inflammatory bowel disease is ulcerative colitis."],"number":12,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 4, wherein the IL-1-related disease, disorder or condition is an inflammatory joint disease."],"number":13,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 13, wherein the inflammatory joint disease is rheumatoid arthritis."],"number":14,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 13, wherein the inflammatory joint disease is osteoarthritis."],"number":15,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 4, wherein the IL-1-related disease, disorder or condition is psoriasis."],"number":16,"annotation":false,"claim":true,"title":false}]}},"filters":{"npl":[],"notNpl":[],"applicant":[],"notApplicant":[],"inventor":[],"notInventor":[],"owner":[],"notOwner":[],"tags":[],"dates":[],"types":[],"notTypes":[],"j":[],"notJ":[],"fj":[],"notFj":[],"classIpcr":[],"notClassIpcr":[],"classNat":[],"notClassNat":[],"classCpc":[],"notClassCpc":[],"so":[],"notSo":[],"sat":[]},"sequenceFilters":{"s":"SEQIDNO","d":"ASCENDING","p":0,"n":10,"sp":[],"si":[],"len":[],"t":[],"loc":[]}}